We specialize in designing cutting-edge small molecule, peptide, and aptamer inhibitors to target pathogens that are notoriously difficult to control--particularly those that have developed or are prone to developing resistance to existing drugs (antibiotics, antivirals, and antifungals) and biocides (fungicides, herbicides, and pesticides). Our advanced peptide/aptamer design tool uniquely balances high selectivity with broad-spectrum efficacy, creating inhibitors that are both precise and versatile in combating resistant pathogens.